Aspira Women’s Health

Aspira Women’s Health is a company listed under the stock ticker AWH (US).

View the org chart displaying its 23 main executives

Most searched biographies at Aspira Women’s Health

• Sandra Milligan, Interim Chief Executive Officer
• Celeste Fralick, Director
• Stefanie Cavanaugh, Independent Director

Popular executive movements at Aspira Women’s Health

• Ellen Beausang has joined the company as Director  (posted on February 11 2025).
• John Kallassy, Interim Chief Financial Officer, has left the company  (posted on January 13 2025).
• Nicole Sandford, Director, President and Chief Executive Officer, has left the company  (posted on December 16 2024).

Click here to view some more movements at Aspira Women’s Health

Create your alert
to follow the executive moves at Aspira Women’s Health.

Aspira Women’s Health has 1,017 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).

Popular M&A news in Medical Equipment

• Kestra Medical Technologies is now listed under the stock ticker KMTS. (posted on March 10 2025).
• OrganOx has just announced a $142 Million fundraising (posted on February 27 2025).
• Videahealth has just announced a $40 Million fundraising (posted on January 31 2025).

Popular contacts in Medical Equipment

• Andrew Elbardissi - Director at Medical Microinstruments
• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific
• Christian Pawlu - Head of Corporate Development at Fresenius SE

Learn more about the Medical Equipment industry >

Press releases by Aspira Women’s Health

• Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
• Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
• Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
• Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
• Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
• Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
• Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
• View more press releases Close

Social media about Aspira Women’s Health

• Aspira Women’s Health on Wikipedia, Google News & Yahoo Finance
• Aspira Women’s Health on LinkedIn, Twitter & YouTube